Compare DexCom, Inc. (DXCM) vs Hershey Co (HSY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs Hershey Co — how do they compare? DexCom, Inc. trades at $77.3 (market cap $28.06B), while Hershey Co trades at $174.78 (market cap $34.54B). The key difference: Hershey Co is the larger of the two by market cap, and Hershey Co pays a 3.41% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals.
| DXCM | HSY | |
|---|---|---|
Market Cap | $28.06B | $34.54B |
Sector | Health | Consumer Staples |
52-Week High | $89.53 | $236.28 |
52-Week Low | $54.84 | $162.31 |
Enterprise Value | $27.03B | $39.34B |
Dividend Yield | — | 3.41% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DXCM trades at $77.31, up 4.3% on the day, with a bullish technical outlook as it approaches resistance near $78. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $0.56 surpassing expectations of $0.47. Revenue growth accelerated to $4.66 billion in 2025, while net income margin expanded to 17.93%. Recent regulatory approvals, including Health Canada authorization for the G7 15-day CGM, support continued international expansion.
The stock offers growth potential with analyst consensus price target of $84.33, though high valuation multiples (P/E 31.21) and competition in the CGM market present risks. Expansion into non-insulin Type 2 diabetes and pediatric markets could drive future revenue, but commercial uptake remains unproven. Institutional sentiment remains strongly bullish with 80% buy ratings.
HSY trades at $174.84, up 1.97% in the last session, with a bearish technical signal but recent earnings beats. The stock shows strong profitability with a 9.12% net income margin and 23.23% ROE, though its P/E of 31.71 suggests premium valuation. Recent news highlights margin recovery and new product launches, with Q2 2026 earnings due July 30, 2026.
Outlook is cautiously optimistic as easing cocoa costs and innovation drive growth, but high debt and valuation pose risks. Analyst consensus is a $209.25 price target with a 'Hold' bias, offering potential upside if earnings momentum continues amid competitive and economic pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About Hershey Co
Hershey is a leading confectionery manufacturer in the U.S. (around a $25 billion market), controlling around 46% of the domestic chocolate space (per IRI). Beyond its namesake label, the firm's mix has expanded over the last 85 years and now consists of 100 brands, including Reese's, Kit Kat, Kisses, and Ice Breakers. Hershey's products are sold in about 80 countries, albeit with just a high-single-digit percentage of sales coming from markets outside the U.S., including Brazil, India, and Mexico. The firm has sought inorganic opportunities to extend its reach beyond its core confection business, adding Amplify Snack Brands and its Skinny Pop ready-to-eat popcorn to its mix and Pirate Brands (including the Pirate's Booty, Smart Puffs, and Original Tings brands) over the past few years.
Read more on HSY →
